开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2024-08-28 ms9000001638905587 来自吉林省

这个怎么样啊，怎么评论这么少

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2023-09-01 ms3000001058974367 来自上海

Decision in Process 5天，还没有消息

65 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2016-01-05 edge25

审稿速度:1.0 | 投稿命中率:50.0
经验分享：7月21日投稿
8月27日大修，10月12日返回
10月28日直接接收。

速度很快效率很高。
人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。
挺好的杂志感觉以后会越来越高。

436 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2017-11-14 lidajiu

审稿速度:1.0 | 投稿命中率:75.0
经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。
with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。
祝福大家！

395 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2020-12-08 ChagallZhang

审稿速度:6.0 | 版面费用:1200.0
偏重的研究方向：药理
经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了

165 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2021-12-22 医者阿杜

With Editor状态已经半个月了，没有动静

97 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2018-02-05 barenlove

审稿速度:6.0 | 投稿命中率:50.0
经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof

381 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2019-05-14 2598959452_12792327

请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表:
请问一定要自己推荐审稿人吗？

小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？

277 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2020-03-13 Isabelleblle

你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表:
您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行

139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行

218 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222893, encodeId=e99322228930f, content=这个怎么样啊，怎么评论这么少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38259426047, createdName=ms9000001638905587, createdTime=Wed Aug 28 19:00:49 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2155656, encodeId=071321556568a, content=Decision in Process 5天，还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80f85489059, createdName=ms3000001058974367, createdTime=Fri Sep 01 21:25:38 CST 2023, time=2023-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=518033, encodeId=21ce518033a5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：7月21日投稿 8月27日大修，10月12日返回 10月28日直接接收。 速度很快效率很高。 人生第一篇SCI，之前投美英杂志被拒4次。改投此日本杂志，因做的药是日本药，研究人群为中国人。且周期较快。一投即中，专家意见评价较好。 挺好的杂志感觉以后会越来越高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=436, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fea51676620, createdName=edge25, createdTime=Tue Jan 05 15:04:00 CST 2016, time=2016-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549190, encodeId=1ec65491909d, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：自认为做的不是特别完整，投时比较忐忑，然而不到一月就接收了……急着毕业的真的可以考虑这个杂志。 with editor 6天，审稿 19天，只返回一个审稿人意见，极小修，周五投回，周一修回with editor，周二接收。从未想过会这么顺利。 祝福大家！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1712128825, createdName=lidajiu, createdTime=Tue Nov 14 15:27:00 CST 2017, time=2017-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905930, encodeId=2102905930c0, content=审稿速度:6.0 | 版面费用:1200.0 偏重的研究方向：药理 经验分享：6月中旬投稿，7月中旬给出大修意见，审核速度还是很快的，审稿人的意见真的很仔细。中途补数据，回复编辑，9月中旬上传大修版本；10月初收到小修意见，改了一周，上传修改版本，11月下旬收到接收邮件。online速度真的是很快了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/icn7m0z1hEPMVic2ZM2VchTVo4QH8FKzCBsCCqdB4Y2fIvicG2ab5C81s3P2vrp0pg0puGDhkibensL7ERfyKZSicMQ/132, createdBy=aee95286113, createdName=ChagallZhang, createdTime=Tue Dec 08 10:49:08 CST 2020, time=2020-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083255, encodeId=da241083255be, content=With Editor状态已经半个月了，没有动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Wed Dec 22 22:49:01 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552392, encodeId=23c5552392ee, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：Completed Accept.版面费已交.为什么好久也没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a41375297, createdName=barenlove, createdTime=Mon Feb 05 00:00:00 CST 2018, time=2018-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570892, encodeId=6ba15e0892b6, content=请问这个杂志上的checklist怎么弄，我研究的是药物单体，从sigma买的，好像每一项都不符合，需要提交吗，小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, beContent=小十二小事儿 2019-04-28 00:00:00 发表: 请问一定要自己推荐审稿人吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/23/2ec9b6a0f54d1d805006ee523c235ef2.jpg, createdBy=810d2581049, createdName=2598959452_12792327, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586555, encodeId=23445865552b, content=你的有消息了吗？139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, beContent=139****0429(暂无匿称) 2020-01-12 00:00:00 发表: 您好，请问你的审稿6个月吗？等着毕业看这个期刊快才投的，结果1.4凌晨提交，都还没有with editor. ,还是手稿提交状态，我都怀疑自己已经投稿成功了。心里焦急的不行, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43c85240713, createdName=Isabelleblle, createdTime=Fri Mar 13 00:00:00 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570151, encodeId=83ec5e0151c1, content=请问一定要自己推荐审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Sun Apr 28 00:00:00 CST 2019, time=2019-04-28, status=1, ipAttribution=)]

2019-04-28 小十二小事儿

请问一定要自己推荐审稿人吗？

215 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务